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ABSTRACT  16 
Various studies have suggested that the gut microbiome interacts with the host and may have a 17 
significant role in the aetiology of obesity and Type 2 Diabetes (T2D). It was hypothesised that 18 
bacterial communities in obesity and T2D differ from control and compromise normal interactions 19 
between host and microbiota. Obesity and T2D were developed in rats by feeding a high-fat diet or a 20 
high-fat diet plus a single low-dose streptozotocin administration, respectively. The microbiome 21 
profiles and their metabolic potentials were established by metagenomic 16S rRNA sequencing and 22 




different from controls and indeed from each other. Diversity was reduced in T2D but not in Obese 24 
rats. Factors likely to compromise host intestinal, barrier integrity were found in Obese and T2D rats 25 
including predicted, decreased bacterial butyrate production. Capacity to increase energy extraction 26 
via ABC-transporters and carbohydrate metabolism were enhanced in Obese and T2D rats. T2D was 27 
characterized by increased proinflammatory molecules. While obesity and T2D show distinct 28 
differences, results suggest that in both conditions Bacteroides and Blautia species were increased 29 
indicating a possible mechanistic link. 30 
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The worldwide incidence of obesity and diabetes mellitus (DM) has significantly increased in recent 39 
years and efforts to address this silently-killing disease are urgently required. During the last decade, 40 
several studies have focused on the role of the gut microbiota in maintenance of gut health and 41 
wellbeing. It has been proposed that an altered microbial-community might result in greater levels of 42 
energy being harvested from food, particularly from a high fat diet, and several mechanisms facilitate 43 
metabolic disorders, particularly Type 2 Diabetes (T2D) [1, 2]. These changes include the production 44 
of short chain fatty acids (SCFAs) and lipopolysaccharide (LPS) which cause chronic low-grade-45 
inflammation [3]. Microbiome-profiling has been developed to determine the metagenomic structure 46 
of bacterial communities based on analysis of 16S rRNA sequences with software such as 47 
Quantitative Insights Into Microbial Ecology (QIIME) [4]. Recently, Phylogenetic Investigation of 48 
Communities by Reconstruction of Unobserved States (PICRUSt) has been developed to provide a 49 
view of metagenome function from 16S rRNA metagenomics or from full genomes [5]. 50 
Rat models have significantly contributed to the study of the function and role of microbiota in the 51 
gastrointestinal tract and its association with diseases such as metabolic disorder and obesity [6, 7], 52 
type 1 diabetes [8-10] and other complex diseases [11]. A model of T2D in rats has been introduced 53 
by Reed et al [12] and subsequently refined by various investigators (reviewed in [13]). The rats are 54 
maintained on a high-fat diet to produce obesity, hyperinsulinaemia, glucose intolerance and insulin 55 
resistance. Subsequent administration of a low dose of streptozotocin results in a reduction of 56 
pancreatic -cell function. We hypothesise that the gut microbiome varies with phenotype and the aim 57 
of the present study was to characterize the composition of gut microbiota using 16S rRNA 58 
sequencing in two rat models: a model of obesity, induced by feeding a high-fat diet; and a model of 59 
T2D induced by high fat diet and a single, low-dose injection of streptozotocin (STZ). The 60 
identification of bacteria that contribute to protection of host and those that cause harm will 61 
potentially open the door to novel therapies for obesity and T2D and will provide clues to links 62 




MATERIALS AND METHODS 64 
Animal maintenance and treatment 65 
In-house-bred, male Wistar rats (age 10-12 weeks, 250-350 g, n=24) were maintained at room 66 
temperature (25°C) and 12/12-hour light-dark cycle and housed in standard cages (3 rats/ cage). At the 67 
beginning of the procedure (week 1), the rats were divided randomly into four groups, with 6 animals 68 
in each group and treated for a period of 12 weeks as described below. After 12 weeks, faecal pellets 69 
were collected from each group early in the morning (7:30 am) from animals housed individually 70 
over-night and immediately stored at -80°C. 71 
Control group: (Normal Diet Vehicle). Rats were fed a normal diet (RM1, Rat and Mouse No. 1 72 
Maintenance Diet; SDS, UK) containing crude fat of 2.7% by weight. Energy provision by component 73 
is: 13% calories from fat, 22% from protein and 65 % from carbohydrate with Gross Energy 14.72 74 
MJ/kg (Summary composition in Table S1; full analysis at http://www.sdsdiets.com/pdfs/RM1P-E-75 
FG.pdf). They received a single intraperitoneal (I/P) injection of citrate buffer (pH 4.4) in a volume of 76 
1 mL kg-1at 4 weeks. Rats were maintained on the same diet for another 8 weeks.  77 
STZ-alone group: (Normal Diet Streptozotocin). Rats were fed a normal RM1 diet and received a 78 
single I/P injection of streptozotocin (STZ) in citrate buffer at 30 mg kg-1at 4 weeks, and maintained 79 
on same diet for another 8 weeks.  80 
Obese group (Ob): (High-Fat Diet Vehicle). Rats were fed a high fat diet (HFD; product code 821424, 81 
SDS, UK) containing crude fat of 22% by weight. Energy provision by component is: 45% calories 82 
from fat, 18% from protein and 37% from carbohydrate with Gross Energy 19.67 MJ/kg (Table S1). 83 
They also received a single I/P injection of citrate buffer (pH 4.4) in a dose of 1 mL kg-1 at 4 weeks. 84 
Rats were maintained on HFD for another 8 weeks. 85 
Diabetic group (T2D): (High-Fat Diet STZ). Rats these rats were fed a HFD and injected I/P with a 86 





Animal weights and blood glucose were measured weekly. Blood glucose levels were measured using 89 
a glucometer (Accu-Check Aviva System; Roche Diagnosis, USA). An insulin tolerance test (ITT) 90 
was carried out in Control (Control; n=3) and Diabetic (T2D; n=3) groups 10 weeks after-the vehicle 91 
or STZ injection. Rats were fasted for 6 hours then received an I/P injection of bovine insulin (1U kg-92 
1; Sigma, UK). Blood samples were collected from the tail tip just before insulin administration (time 93 
0) and at 30, 60, and 120 minutes after glucose/insulin injection for measurement of blood glucose 94 
concentration using the glucometer. 95 
Bacterial DNA extraction from faecal pellets and Illumina MiSeq sequencing  96 
Genomic DNA was isolated, within one day of faecal collection using the QIAamp DNA Stool Mini 97 
Kit (QIAGEN Manchester Limited (UK)) following the manufacturer’s protocol. Separate isolations 98 
were made from three individual pellets/animal with material being taken from three separate 99 
locations on each pellet (180-220 mg for each animal), then placed in a 2 mL Lysing Matrix E (4 mm 100 
glass beads) microcentrifuge tubes (MP Biochemicals, Strasbourg). Tube contents were thoroughly 101 
homogenized in ASL Buffer using a FastPrep®-24 Instrument (MP Biomedicals, UK) at 4.5 M 102 
second-1 for 30 seconds. A single DNA sample for each individual animal was recovered by pooling 103 
equal quantities of the separate DNA preparations and stored at -80°C prior to sequencing. 104 
Purified DNA was used for PCR amplification and sequencing of 16S rRNA genes on an Illumina 105 
MiSeq instrument with 2 x 300 base-pair paired-end reads at GATC Biotech (Germany). Universal 106 
primers of 16S rRNA genes were used to amplify the hypervariable regions, V3-V5 (V3F (357F), 107 
V5R (926R)). In a second PCR, Illumina TruSeq adapters and tag sequences were attached prior to 108 
sequencing. Reads have been submitted to the SRA with Accession Number SRP152214. 109 
Bioinformatics and statistical analysis 110 
Sequences were provided in a demultiplexed format and processed using Quantitative Insights Into 111 
Microbial Ecology (QIIME) v 1.8.0 [4]. Paired reads were merged (minimum overlap 18, tolerance 5) 112 
and quality filtered with default settings. Filtered sequences were clustered into Operational 113 
Taxonomic Units (OTUs) at 97% sequence similarity and Chimera sequences removed using 114 
USEARCH [14]. The most abundant sequences for each OTU were used as a representative to 115 




prior to filtering with default settings.  Alpha- and beta-diversity were calculated in QIIME using the 117 
OTU table. 118 
Predicted molecular functions were generated from the taxonomy frequencies using PICRUSt [5] 119 
following the workflow described at 120 
https://github.com/LangilleLab/microbiome_helper/wiki/PICRUSt-workflow. It is important to note 121 
that this approach produces only predictions of metabolic function. The OTU table produced by 122 
QIIME was converted to .biom format (http://biom-format.org/documentation/biom conversion.html) 123 
before a filtering step to remove those entries which do not have an identified organism. The filter-124 
command produced a closed reference .biom table. Entries to this table were normalised to 16S rRNA 125 
gene copy number to provide abundance numbers for each OTU. Kyoto Encyclopedia of Genes and 126 
Genomes (KEGG) orthologs (KOs) were then predicted prior to them being collapsed at level three to 127 
provide Pathway predictions. The abundance data was normalized to the geometric mean [16] of 128 
values for ‘house-keeping’ functions in genetic information processing [5]. To evaluate the 129 
significance of particular taxa to defined Pathways (L3) within each group, the predicted contribution 130 
of taxa, identified by regression analysis as being connected to the pathway, were summed. 131 
Relative abundance is presented as mean +/- SEM and differences within and between groups were 132 
assessed using GraphPad Prism 6 by: Dunn’s multiple comparison tests after one-way ANOVA; 133 
Bonferroni multiple comparison tests after two-way ANOVA for differences among more than two 134 
groups; Dunnett’s multiple comparison tests after two-way ANOVA to compare differences between 135 
the control group and other groups. A p value of < 0.05 was considered significant. Principal 136 
Coordinates Analysis (PCoA), heat map and hierarchical clustering analysis were conducted with the 137 
R software package version 3.2.1 (https://cran.r-project.org/bin/windows/base/old/3.2.1) to compare 138 





Induction of obesity and T2D in rats 141 
Rats fed a high-fat diet and injected with vehicle exhibited a significant increase in body weight (p < 142 
0.05 vs (versus) all other groups; Fig. 1a). Treatment with a high-fat diet and a low dose of STZ 143 
(T2D) induced a significant increase in blood glucose; significant hyperglycaemia was observed 1 144 
week post-STZ injection in T2D rats (p < 0.05 vs all other groups) and this was maintained until the 145 
end of the study (Fig. 1b). The insulin tolerance test revealed that T2D rats were insensitive to insulin 146 
compared to control rats and displayed significant hyperglycaemia for the duration of the test (all p < 147 
0.05 vs Controls; Fig. 1c). 148 
Phylogenetic composition and the relative abundance of taxa of the microbiome communities 149 
Basic statistics for the number of reads and clusters of similar sequences for all four groups are shown 150 
in Table S2. Determination of the 16S rRNA sequences allowed phylogenetic classification via 151 
QIIME of OTUs of the gut microbiota from the level of phylum to family or genus. At phylum level 152 
(Fig. S1) Bacteroidetes predominate over Firmicutes in the control group while similar levels for each 153 
were found in the STZ-alone animals. In contrast the proportion of each switch in the Obese and T2D 154 
groups and Firmicutes now predominate followed by Bacteroidetes. The proportion of Firmicutes was 155 
significantly higher (p < 0.0001 and p < 0.001) in T2D compared to both control and STZ-alone, 156 
while the abundance of Bacteroidetes was significantly lower (p< 0.0001 and 0.001). Firmicutes was 157 
enriched (p < 0.0001) and Bacteroidetes lower (p < 0.01) in Obese compared to STZ-alone while it 158 
was higher (p < 0.05) in STZ-alone vs control (Fig. S1) and (p < 0.01) in T2D vs Obese.  159 
At family level S24-7 family was the most abundant in both control and STZ-alone followed by 160 
various other families while in Obese, Ruminococcaceae was the predominant family and in T2D, 161 
Lachnospiraceae was the predominant family (Fig. S2). When comparing bacteria at family levels, no 162 
significant differences were found between control and STZ-alone but differences were found for all 163 
other pairwise comparisons of the groups (Fig. S3). For instance Bacteroidaceae and 164 
Lachnospiraceae were significantly enriched (p < 0.0001) in the T2D vs control and vs STZ-alone, 165 




0.0001). There were significant differences between nine families when Obese was compared to 167 
control and with STZ-alone while there were eight significant differences between Obese and T2D. 168 
The abundant bacteria at genus level differ between the four experimental groups and are shown in 169 
Fig. 2 and Table S3. In the control animals, the most abundant genera were Prevotella from 170 
Prevotellaceae family, while in the STZ-alone animals, the most abundant genera Prevotella and 171 
noticeably Allobaculum from Erysipelotrichaceae family. In the Obese group, Bacteroides from 172 
Bacteroidaceae family, [Prevotella] from [Paraprevotellaceae] family, Oscillospira and 173 
Ruminococcus from Ruminococcaceae family and Prevotella occur at highest levels. In T2D, the most 174 
abundant genera were Bacteroides, Prevotella and Blautia from Lachnospiraceae family. Fig. 3 175 
shows the comparison of bacterial genera between the groups. Comparison of genera in control vs 176 
STZ-alone showed no statistical difference but differences were apparent for all other groups. For 177 
instance a higher proportion of Blautia and Bacteroides were found in T2D vs both control and STZ-178 
alone while Allobaculum was higher in T2D vs control (p < 0.0001) (Fig. 3). Noticeably the ratio of 179 
Bacteroides/Prevotella was much higher in Obese and T2D than both control and STZ-alone (Fig. S4). 180 
Differences between genera in bacterial communities or groups were also apparent when data was 181 
analysed by PCoA and hierarchical clustering (not shown). The PCoA was conducted in a pairwise 182 
manner and is shown in Fig. 4 and reveals spatial separations between the groups. The exception was 183 
between control and STZ-alone which could not be resolved and were overlapping or very close to 184 
each other (Fig. 4a). In contrast, Obese and T2D rats showed distinct differences when compared to 185 
the control group (Fig. 4b and c). 186 
The differences in diversity of taxa across the groups were also shown by measures of both α- and β-187 
diversity. Fig. 5 illustrates α-diversity determined as PD-whole-tree, chao1 and observed-species. 188 
Each of the measures showed a significant reduction in diversity in T2D compared to control. α-189 
diversity in T2D was also significantly lower than in Obese rats. The distance-difference of 190 
Unweighted and Weighted UniFrac β-diversity was measured for the bacterial community in the 191 
individual animals, pairwise, with animals within the same group and between groups (Table S4). Fig. 192 
S5 shows the separations of the distance matrix among the four groups with the exception of control 193 




The functional microbiome  195 
The potential for bacterial metabolism in each bacterial group has been provided by PICRUSt. The 196 
normalised data was analysed by KEGG Category (level 2 e.g. Carbohydrate metabolism) and 197 
Pathway (level 3 e.g. Butanoate metabolism), PCoA, heatmaps and hierarchical clustering and results 198 
are shown in Fig. 6 and Fig. S6. So as to focus on major functional activities, analysis of these data 199 
was made at level 2 and significant differences were found between the four groups in transcription, 200 
translation, amino acid metabolism, biosynthesis of other secondary metabolites, carbohydrate 201 
metabolism, energy metabolism, enzyme families, glycan biosynthesis and metabolism, metabolism 202 
of cofactors and vitamins, nucleotide metabolism and xenobiotic biodegradation and metabolism (Fig. 203 
S6). PCoA showed spatial separation of all groups (Fig. 6a). Fig. S6 shows the hierarchical clustering 204 
and heatmaps among the four experimental groups and these data show again a clear separation. 205 
Because of the role of short-chain fatty acids in gut health, butyrate and propionate metabolism were 206 
analysed at level 3. Fig. 6b shows that butyrate production was significantly lower in T2D compared 207 
to other groups. The level of propionate was also determined by group and metabolism was 208 
significantly reduced in T2D vs both control and Obese (Fig. 6b). Glycolysis/gluconeogenesis, 209 
metabolism of starch and sucrose and fructose and mannose and ABC transporters were significantly 210 
higher in Obese and T2D vs both control and STZ-alone groups and also T2D vs Obese (Fig. 6c). 211 
Processes producing bacterial-derived inflammatory molecules were also affected as shown in Fig. 6d. 212 
Bacterial biosynthesis of Lipopolysaccharide (LPS) and LPS biosynthesis proteins were higher in 213 
Obese and T2D, while peptidoglycan biosynthesis and bacterial toxins were higher in T2D compared 214 
to the other three groups.  215 
Correlation coefficients have been calculated to analyse the relationship of SCFA metabolism and 216 
LPS biosynthesis to individual gut microbiota (Fig. S7). It was found that Turicibacter genus and 217 
undefined genus of both S24-7 and Peptostreptococcaceae families were positively correlated to the 218 
butyrate production while genus of Blautia, and [Ruminococcus] and unclassified genus of 219 
Lachnospiraceae family were negatively associated with butyrate production. Both Ruminococcus and 220 
[Prevotella] (without STZ-alone) were positively linked to propionate metabolism. Also, Bacteroides 221 
was positively correlated with LPS biosynthesis. The relative abundances of bacteria that either 222 





This study describes altered composition and metabolic potential of gut microbiota in rats fed with a 225 
diet containing high fat content that induced obesity or in combination with a single, low-dose STZ 226 
injection that induced T2D. Rats fed with HFD plus low-dose STZ developed insulin-insensitivity and 227 
hyperglycaemia consistent with the phenotype of T2D while STZ-alone caused no lasting 228 
physiological changes. Diabetic rats had weight loss as a result of loss of calories from sugar in the 229 
urine and the consequence of fat cell breakdown for energy production [9]. This is in contrast to 230 
Obese rats who exhibited a significant increase in body weight but with no change in blood glucose 231 
levels. 232 
In this study the most abundant bacterial phyla were the Firmicutes and the Bacteroidetes (Fig. S1) 233 
and there was a significant change in the relative abundance of these phyla in the diabetic animals. 234 
Similar changes have been observed in obesity in human [17]. 235 
PICRUSt metabolic analysis indicates potential bacterial-derived metabolic capabilities and 236 
specifically on metabolism of SCFA, including butyrate or propionate and on inflammatory molecules 237 
that are increased in both the obese and diabetic condition. In this study predictions for levels of 238 
butyrate indicate that this metabolite would be decreased in both the Obese and T2D rats compared to 239 
those on the normal diet. At variance with this are the results from a meta-analysis of 8 data sets using 240 
PICRUSt to make predictions and found that these pathways would be increased [18]. It is likely that 241 
the conflict between our predictions and those of Jiao et al [18] are a consequence of their use of a 242 
mixture of genera (5 mice, 3 rats) with variant species of each genus. It is generally accepted that 243 
butyrate production is beneficial and thus decreased production in Obese and T2D may be expected 244 
and those predictions could be tested in further experimentation. Butyrate is protective of the single 245 
cell-layer of epithelial cells along with its mucin coating while this barrier is compromised by 246 
inflammatory molecules [19]. In this study, the most abundant taxa in the control animals were 247 
unclassified genus of S24-7 family, Turicibacter genus and unclassified genus of 248 
Peptostreptococcaceae family (Fig. 2). PICRUSt positively linked these bacteria to butyrate 249 
production (Fig. S7) and they have been identified as butyrate-producing bacteria (S24-7 family [20], 250 
Peptostreptococcaceae family [21], and Turicibacter genus [22]). Butyrate is produced as a bacterial 251 




promotes the synthesis and secretion of mucin into the intestine [9, 24], stimulates Claudin-1, a 253 
protein of tight-junctions [25] and acts as an anti-inflammatory [26]. Butyrate is also important in the 254 
activation of host GRP41/43 that elicits production of appetite-suppressing PYY and insulin-255 
producing GLP1 [27]. In the STZ-alone rats, there was no significant difference in bacterial profile 256 
compared to control at the level of genus with the exception of an increase of Allobaculum genus (Fig. 257 
2 and Fig. 3). A study of gut microbiota in mice [28] found that mice fed with low fat diet showed an 258 
enrichment of this genus. In fact, Allobaculum in the intestine encourages mucin release because this 259 
bacterium produces butyrate [29]. We found no difference in our predictions between Control and 260 
Obese groups for propionate metabolism again in contrast to the predictions of Jiao et al [18] but 261 
consistent with the predictions of Lee and Ko [30] who found an improvement in metabolic 262 
parameters and increased propionate in metformin administered mice on a high fat diet. Our results for 263 
predictions on butyrate and propionate are also in accord with a chemical study of human subjects and 264 
both of these short chain fatty acids were decreased in faecal material from patients with T2D [31]. 265 
Additionally, a study employing genome-wide genotyping and gut metagenomic sequencing of a large 266 
panel of human subjects found a positive association between butyrate production and good insulin 267 
response to oral glucose administration [32].  268 
The data from Obese rats highlighted the significant increase in Firmicutes phylum and associated 269 
decrease in Bacteroidetes. There was a significant enrichment of genus Bacteroides and a reduction of 270 
genus Prevotella in Obese rats compared to both control and STZ-alone groups. Bacteroides is a 271 
Gram-negative bacterium and is able to digest a variety of polysaccharides [33] producing fructose 272 
from fructans and then saccharolytic fermentation, produces acetate which is used for methanogenesis 273 
by Methanobrevibacter smithii [34]. Acetate is also utilised in energy metabolism by the host leading 274 
to increased adipose tissue. In the Obese rats, there was enrichment of [Prevotella]/ 275 
[Paraprevotellaceae] and this bacterium was predicted to be positively associated with propionate 276 
metabolism (Fig. S7). Ruminococcus and Oscillibacter were increased in the Obese rats (Fig. 3). 277 
Some Ruminococcus sp are acetate producers [35] and R. bromii and R. obeum were associated with 278 
obesity [36] and here a positive correlation between Ruminococcus and predicted propionate 279 
metabolism was found (Fig. S7). There are three pathways of propionate metabolism and the 280 
association between Ruminococcus sp. and one of these has recently been confirmed in the human gut 281 




species of Ruminococcus genus and Lachnospiraceae family. Krych et al., [38] showed that the 283 
occurrence of bacteria such as Lachnospiraceae family, and both genera Oscillospira and 284 
Ruminococcus from Ruminococcaceae family are associated with the promotion of diabetes. 285 
Perhaps the most dramatic changes in bacterial communities were found in the rats in which T2D had 286 
been induced. Further these changes appear to be associated with the physiological state expected of a 287 
diabetic animal. The diabetic rats had a decreased ratio of Firmicutes/ Bacteroidetes despite an 288 
increase of Bacteroides. The increase of Bacteroides was positively correlated with predicted LPS 289 
biosynthesis. Blautia was also increased and is a gram-positive, non-sporulating coccobacillus 290 
belonging to the Firmicutes phylum [39]. In humans Blautia was the predominant genus in pre-291 
diabetic and T2D patients [40] and plays a vital role in the metabolism of glucose which it converts to 292 
acetate, lactate, hydrogen, ethanol and succinate in the gut [39]. A recent report by Ozato et al., [41] 293 
found that visceral fat in individuals in a Japanese population was inversely associated with Blautia. 294 
In our study Blautia was not significantly different in the Obese animals compared to the Control, 295 
however, our measure of Obesity was body weight rather than visceral fat. The predicted increase of 296 
bacterial gut-derived inflammatory molecules (for instance, LPS, flagellin and peptidoglycans) and 297 
predicted decreased butyrate production would be likely to be associated with the causation of 298 
inflammation and T2D [42]. Increased permeability of the gut membrane and low level inflammation 299 
caused by LPS and bacterial toxins has been reviewed [43]. 300 
As a working hypothesis we propose that the relationship between diet and the role of either beneficial 301 
or harmful gut microbiota in Wistar rats is that summarized in Fig 7. The taxonomy of the bacterial 302 
communities and the bacterial metabolic capabilities were comparable in both control groups and 303 
predicted to promote the production of mucin and protection of the gut barrier layer. On the other 304 
hand, there were significant differences in the bacterial communities and metabolic potential in the 305 
Obese and T2D rats. Changes from a high ratio of Prevotella/ Bacteroides in controls to a low ratio in 306 
the T2D animals (data not shown) are associated with a healthy to diabetic transition and similar 307 
conclusions have been reached in humans and mice [44]. This is diet associated and these differences 308 
were observed when comparing both groups on a normal diet to both groups on a high fat diet. In 309 
humans Prevotella is associated with plant-based diets [45] and the normal diet provided for control 310 




(http://www.sdsdiets.com/pdfs/RM1P-E-FG.pdf). However, single-component diet change does not 312 
itself bring about a change in Prevotella/ Bacteroides ratio or a loss of body weight [46]. Intervention 313 
is clearly context specific and the development of therapies for metabolic diseases will need to be 314 
mindful of the antagonistic interaction between Prevotella and Bacteroides [47], dietary presence of 315 
complex carbohydrates or presence of a fat- and protein-rich diet. 316 
Obesity predisposes to T2D but this is not the case in all instances of the disease [48, 49]. Identifying 317 
the pathway from obesity to T2D and the role of the gut microbiome is especially difficult because of 318 
the interaction of a large number of gut organisms, many of which have not been identified, with each 319 
other and the host and the balance between harmful and beneficial interactions [50]. Seeking links 320 
between obesity and T2D is not revealed by this study but some clues are provided. Blautia is present 321 
in Obese rats and significantly elevated in T2D rats. This is predicted to disrupt carbohydrate and 322 
glucose metabolism that reduces butyrate production with an increase of other SCFA and these 323 
products may contribute to energy capture by the host [51, 52]. The one common feature of the 324 
microbial changes in both Obese and T2D rats is the increase of Bacteroides. Bacteroides are uniquely 325 
able to regulate the expression of genes for polysaccharide degradation and uptake and these are 326 
determined by the identity and availability of specific polysaccharides. They do this through different 327 
gene cassettes that are differentially controlled by intermediates of the breakdown process and may 328 
differ between species [53]. Thus we hypothesise that species within Blautia and Bacteroides are 329 
significantly associated with both Ob and T2D possibly as a mechanistic driver. The animal models 330 
share many characteristics that have been described from studies of humans either of obesity or T2D 331 
and future work may profit from a focus on Blautia and Bacteroides in these animal models and 332 
identifying which specific species in the two genera are altered. 333 
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Figure Legends 508 
Fig. 1 Total weight gain (g) from week 0 to week 12 (a),  blood glucose (mmol/L) measured on week 509 
12 (b) in Control, STZ-alone, Obese  and Diabetic rats (n=6/group), and the insulin tolerance test 510 
compared Diabetic vs Control rats (c). Data are mean ± SEM.  Significant difference from all other 511 
groups 512 
Fig. 2 Bacterial taxonomy and abundance of the gut metagenome (a) at genus level between the four 513 
experimental groups  514 
Fig. 3 Differences in abundance of genera between the four experimental groups  515 
Fig. 4 Comparison of bacterial communities at genus level in the four experimental groups based on 516 
PCoA 517 
Comparisons are pairwise for individual rats in each group (n=6); Control green, STZ-alone red, 518 
Obese blue and Diabetic black. 519 
Fig. 5 Bacterial α-diversity of bacterial communities in the four experimental groups 520 
Dunn's multiple comparisons test was used to determine the relationship of α-diversity between the 521 
microbiome of the rat groups (n=6).*p<0.05, **p<0.01, and ***p<0.001.  522 
Fig. 6 PICRUSt analysis for predictions of the functional microbiome of each group  523 
PICRUSt was conducted at level 3. PCoA was used with individuals (a). The Mann Whitney test was 524 
used to estimate the significant differences; Metabolism of SCFA (butyrate and propionate) (b); 525 
energy related metabolism (glycolysis/ gluconeogenesis, starch and sucrose metabolism, fructose and 526 
mannose metabolism, and ABC transporters) (c) and processes producing bacterial-derived 527 
inflammatory molecules (d) Bacterial biosynthesis of lipopolysaccharide (LPS), LPS biosynthesis 528 
proteins, Bacterial toxins and Peptidoglycan biosynthesis.  529 
Fig. 7 A model of the interactions between gut and microbial communities in normal (a), diabetic (b) 530 




Supplementary Figure Legends 532 
Figure S1: Bacterial taxonomy at phylum level (a) and differences in abundance of phyla (b)  533 
The Bonferroni’s comparison test was used to estimate the relationship of bacterial phyla between the 534 
groups (n=6/ group).  535 
Figure S2: Bacterial taxonomy at family level  536 
Figure S3 Differences in abundance of family between the four experimental groups  537 
The Bonferroni’s comparison test was used to estimate the relationship of bacterial families between 538 
the groups (n=6/ group).  539 
Figure S4 Ratio of Bacteroides/Prevotella among the four groups 540 
Figure S5: Bacterial β-diversity (weighted UniFrac) of the microbial communities 541 
The bacterial communities of individual rats based on the weighted UniFrac by PCoA.  542 
Figure S6: PICRUSt analysis for predictions of microbial communities at level 3; Hierarchical 543 
clustering (a) and heatmap (b) 544 
Hierarchical clustering and Heat map analysis by R statistic (n=6). The Hierarchical clustering was 545 
used to confirm the similarity of bacterial function between the groups. Heatmap was use to illustrate 546 
the relative abundant of each individual bacterial function among these four groups.  547 
Figure S7: Correlations between bacteria and predicted metabolic activities 548 
Linear correlation Pearson coefficients and nonparametric Spearman were used to show the 549 
relationship of gut bacteria either with SCFAs (butyric acid (a), propionic acid (b) ) and LPS 550 
biosynthesis (c) and the relative abundance of bacteria that produce butyric acid (d) and propionic acid 551 






Supplementary Table Legends 555 
Table S1: Composition (% of total) of the standard animal house diet (RM1) and high fat diet (HFD): 556 
(a) Nutrients (b) carbohydrate, fiber and non-starch polysaccharides and (c) fatty acids  557 
Table S2: Quality control and OTU assignments of the NGS Illumina MiSeq reads of the four rat 558 
experimental groups  559 
The data shows numbers of reads for individual animals after quality trimming (phred > 20), merging 560 
of pairs, similarity-clustering and chimera identification. OTUs were assigned before filtering to show 561 
best hit only. Key: NDV = normal diet; NDS = normal diet plus STZ injection; HFV = high fat diet 562 
(Obese); HFS = high fat diet plus STZ injection (Diabetic). 563 
Table S3: Bacterial taxonomy at genera level 564 
The Phylogenetic analysis at genus level of faecal 16S rRNA for the four experimental groups (n=6/ 565 
group). The mean abundance (%) from the bacterial taxonomic profiling is shown. Values <0.01% 566 
show as 0.00 due to decimal point truncation.  567 
Key Control= normal diet; STZ-alone= normal diet plus STZ injection; Obese= high fat diet and 568 
Diabetic= high fat diet plus STZ injection.  569 
 570 
Table S4: Differences of bacterial beta diversity: unweighted (a) and weighted (b) in the individual 571 
animal samples  572 
Key: NDV = normal diet; NDS = normal diet plus STZ injection; HFV = high fat diet (Obese); HFS = 573 















*p<0.05, ** p<0.01, ***p<0.001, ****p< 0.0001 
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Table S1: Composition (% of total) of the standard animal house diet (RM1) and high fat diet 
(HFD): (a) Nutrients (b) carbohydrate, fiber and non-starch polysaccharides and (c) fatty acids  
a) Nutrients   
  Standard Diet (RM1) (%) HFD (%) 
Moisture  10 7.46 
Crude Oil 2.71 22.27 
Crude Protein 14.38 19.87 
Crude fibre 4.65 3.91 
Ash 6 5.24 
Nitrogen Free Extract 61.73 41.02 
 
b) Carbohydrate, fibre, and non-starch polysaccharide   
  Standard Diet (RM1) (%) HFD (%) 
Pectin  1.52 0.46 
Hemicellulose 10.17 3.17 
Cellulose 4.32 4.85 
Lignin 1.68 0.43 
Starch 44.97 34.74 
 
c) Fatty Acids     
  RM1 (%) Total (%) HFD (%) Total (%) 
Saturated Fatty Acid     




        C14:0 Myristic 0.14 0.37 
        C16:0 Palmitic 0.31 4.56 
        C18:0 Stearic 0.04 2.04 
Monounsaturated Fatty Acids     
C14:1 Myristoleic 0.02 
0.88 
0.03 
6.83 C16:1 Palmitoleic 0.09 0.11 
          C18:1 Oleic 0.77 6.69 
      
Polyunsaturated Fatty Acids     




        C18:3 Linolenic 0.06 0.11 
        C20:4 Arachidonic 0.13 0.03 
        C22:5 Clupanodonic 0.00 0.00 
4 
 
Table S2: Quality control and OTU assignments of the NGS Illumina MiSeq reads of the four rat experimental groups  
A 







pairs Read pairs 
% Read 










pairs Read pairs 
% Read 
pairs Read pairs 
% Read 
pairs 
Total 780,941 100 737,400 100 716,068 100 737,118 100 644,102 100 796,571 100 4412200 100 
Cleaned 231,294 29.6 229,708 31.2 207,409 29 219,892 29.8 185,833 28.9 232,308 29.2 1306444 29.62 
Cleaned (orphan) 309,687 39.7 307,886 41.8 293,119 40.9 300,765 40.8 263,972 41 331,626 41.6 1807055 40.92 
Merged by overlapping 228,867 29.3 227,768 30.9 205,316 28.7 217,153 29.5 184,050 28.6 229,897 28.9 1293051 29.32 
Clustered by similarity 150,689 19.3 191,096 25.9 178,638 24.9 146,366 19.9 115,335 17.9 150,764 18.9 932888 21.13 
Chimeric 17,410 2.2 25,966 3.5 17,913 2.5 13,754 1.9 12,903 2 10,382 1.3 98328 2.23 
Final high quality 133,279 17.1 165,130 22.4 160,725 22.4 132,612 18 102,432 15.9 140,382 17.6 834560 18.90 
OTU assigned 105,777 79.4 140,650 85.2 133,319 82.9 106,433 80.3 80,746 78.8 110,486 78.7 677411 80.88 
Filter passed OTUs (best hit only) 22,682 17 34,358 20.8 37,209 23.2 17,652 13.3 10,348 10.1 18,763 13.4 141012 16.3 
Filter passed OTUs (all hits) 22,682 17 34,350 20.8 37,201 23.1 17,652 13.3 10,348 10.1 18,763 13.4 140996 16.28 
 
b         







pairs Read pairs 
% Read 










pairs Read pairs 
% Read 
pairs Read pairs 
% Read 
pairs 
Total 932,125 100 869,327 100 909,084 100 884,318 100 727,318 100 993,913 100 5316085 100 
Cleaned 288,646 31 262,287 30.2 270,190 29.7 293,657 33.2 189,592 26.1 290,452 29.2 1594824 29.9 
Cleaned (orphan) 373,270 40 358,907 41.3 367,897 40.5 346,172 39.1 313,070 43 397,420 40 2156736 40.65 
Merged by overlapping 286,361 30.7 259,753 29.9 267,166 29.4 291,732 33 187,310 25.8 287,512 28.9 1579834 29.62 
Clustered by similarity 208,704 22.4 189,540 21.8 216,130 23.8 256,326 29 161,039 22.1 234,675 23.6 1266414 23.78 
Chimeric 21,152 2.3 32,822 3.8 28,010 3.1 37,134 4.2 7,430 1 17,777 1.8 144325 2.7 
Final high quality 187,552 20.1 156,718 18 188,120 20.7 219,192 24.8 153,609 21.1 216,898 21.8 1122089 21.08 
OTU assigned 149,695 79.8 124,893 79.7 157,651 83.8 183,926 83.9 129,112 84.1 182,741 84.3 928018 82.6 
Filter passed OTUs (best hit only) 24,261 12.9 31,940 20.4 48,774 25.9 40,427 18.4 33,804 22 33,137 15.3 212343 19.15 




Continued Table S2 
 
C 







pairs Read pairs 
% Read 
pairs Read pairs 
% Read 
pairs Read pairs 
% Read 






pairs Read pairs 
% Read 
pairs 
Total 878,903 100 841,564 100 1,031,154 100 546,750 100 915,912 100 850,833 100 5065116 100 
Cleaned 249,017 28.3 243,693 29 278,030 27 163,812 30 255,233 27.9 253,862 29.8 1443647 28.67 
Cleaned (orphan) 349,489 39.8 340,241 40.4 416,247 40.4 220,348 40.3 384,532 42 337,435 39.7 2048292 40.43 
Merged by overlapping 246,691 28.1 241,673 28.7 275,510 26.7 162,487 29.7 253,048 27.6 251,584 29.6 1430993 28.4 
Clustered by similarity 156,214 17.8 192,396 22.9 177,636 17.2 124,932 22.8 167,755 18.3 216,273 25.4 1035206 20.73 
Chimeric 15,427 1.8 22,686 2.7 15,126 1.5 20,483 3.7 30,723 3.4 19,366 2.3 123811 2.57 
Final high quality 140,787 16 169,710 20.2 162,510 15.8 104,449 19.1 137,032 15 196,907 23.1 911395 18.2 
OTU assigned 106,370 75.6 140,862 83 124,745 76.8 86,469 82.8 109,546 79.9 164,443 83.5 732435 80.27 
Filter passed OTUs (best hit only) 9,652 6.9 29,884 17.6 15,635 9.6 21,614 20.7 31,066 22.7 38,746 19.7 146597 16.2 
Filter passed OTUs (all hits) 9,652 6.9 29,876 17.6 15,635 9.6 21,609 20.7 31,066 22.7 38,732 19.7 146570 16.2 
 
D 







pairs Read pairs 
% Read 
pairs Read pairs 
% Read 
pairs Read pairs 
% Read 






pairs Read pairs 
% Read 
pairs 
Total 879,377 100 870,058 100 830,865 100 785,820 100 893,885 100 926,068 100 5186073 100 
Cleaned 269,265 30.6 256,001 29.4 254,992 30.7 251,249 32 289,821 32.4 296,895 32.1 1618223 31.2 
Cleaned (orphan) 346,312 39.4 336,857 38.7 321,220 38.7 306,594 39 336,654 37.7 348,570 37.6 1996207 38.52 
Merged by overlapping 266,270 30.3 253,241 29.1 252,249 30.4 249,861 31.8 287,632 32.2 293,742 31.7 1602995 30.92 
Clustered by similarity 230,592 26.2 210,571 24.2 209,732 25.2 183,267 23.3 218,448 24.4 229,017 24.7 1281627 24.67 
Chimeric 41,212 4.7 39,929 4.6 51,804 6.2 47,859 6.1 63,757 7.1 67,893 7.3 312454 6 
Final high quality 189,380 21.5 170,642 19.6 157,928 19 135,408 17.2 154,691 17.3 161,124 17.4 969173 18.67 
OTU assigned 166,818 88.1 144,466 84.7 130,191 82.4 111,649 82.5 120,478 77.9 124,040 77 797642 82.1 
Filter passed OTUs (best hit only) 87,557 46.2 66,175 38.8 68,890 43.6 51,956 38.4 54,679 35.3 73,728 45.8 402985 41.35 
Filter passed OTUs (all hits) 87,554 46.2 66,173 38.8 68,888 43.6 51,951 38.4 54,679 35.3 73,728 45.8 402973 41.35 
The data shows numbers of reads after quality trimming (phred > 20), merging of pairs, similarity-clustering and chimera identification. OTUs were assigned before 








*P<0.05, ** P<0.01, ***P<0.001, ****P< 0.0001 
Figure S1: Bacterial taxonomy at phylum level (a) and differences in abundance of phyla (b)  
 
The Bonferroni’s comparison test was used to estimate the relationship of bacterial phyla between the 














*P<0.05, ** P<0.01, ***P<0.001, ****P< 0.0001 
Figure S3: Differences in abundance of families between the four experimental groups  
 
The Bonferroni’s comparison test was used to estimate the relationship of bacterial families between 





Table S3: Bacterial taxonomy at genera level 
Phylum Family Genus Control STZ-alone Obese Diabetic 
p_Actinobacteria 
f_Bifidobacteriaceae g_Bifidobacterium 0.00 0.00 0.01 0.00 
f_Coriobacteriaceae 
f_Coriobacteriaceae_g__ 0.14 0.13 0.14 0.14 
g_Adlercreutzia 0.14 0.13 0.14 0.00 
g_Atopobium 0.00 0.13 0.00 0.00 
g_Collinsella 0.00 0.00 0.00 0.14 
p_Bacteroidetes 
o_Bacteroidales_ o_Bacteroidales_g_ 0.69 0.13 1.37 1.21 
f_Bacteroidaceae g_Bacteroides 0.42 0.00 11.13 8.36 
f_Porphyromonadaceae g_Parabacteroides 0.14 0.13 0.41 0.40 
f_Prevotellaceae g_Prevotella 11.25 9.57 5.36 12.80 
f_RF16 f_RF16_g__ 0.28 0.13 1.92 0.14 
f_Rikenellaceae f_Rikenellaceae_g__ 0.14 0.00 0.28 0.00 
f_S24-7 f_S24-7_g__ 38.19 36.84 11.54 9.16 
f_[Odoribacteraceae] g_Odoribacter 0.00 0.00 0.11 0.00 
f_[Paraprevotellaceae] 
f_[Paraprevotellaceae]_g_ 0.00 0.00 0.00 0.00 
g_CF231 0.83 0.27 2.47 0.67 
g_Paraprevotella 0.00 0.00 0.14 0.00 
g_YRC22 1.11 0.40 0.82 0.40 
g_[Prevotella] 1.94 0.53 8.65 1.08 
p_Cyanobacteria o_YS2 o_YS2_g__ 0.14 0.00 0.41 0.00 
p_Deferribactere
s 
f_Deferribacteraceae g_Mucispirillum 0.00 0.00 0.00 0.14 
p_Elusimicrobia f_Elusimicrobiaceae f_Elusimicrobiaceae_g__ 0.00 0.00 0.00 0.00 
p_Firmicutes 
f_Lactobacillaceae g_Lactobacillus 0.00 0.00 0.14 0.40 
f_Turicibacteraceae g_Turicibacter 4.44 1.86 0.00 4.58 
o_Clostridiales_Other o_Clostridiales_Other 0.00 0.27 0.00 0.14 
o_Clostridiales_ o_Clostridiales_g__ 6.39 7.31 20.88 7.28 
f_Christensenellaceae f_Christensenellaceae_g_ 0.00 0.00 0.00 0.00 
f_Clostridiaceae 
f_Clostridiaceae_g__ 5.83 7.98 0.14 5.93 
g_Clostridium 0.56 0.67 0.00 1.08 
g_SMB53 0.14 0.00 0.00 0.00 
f_Lachnospiraceae 
f_Lachnospiraceae_Other 0.00 0.00 0.28 0.14 
f_Lachnospiraceae_g__ 0.97 1.06 2.34 2.29 
g_Anaerostipes 0.14 0.13 0.00 0.00 
g_Blautia 0.14 0.13 1.65 10.65 
g_Coprococcus 0.28 0.67 1.65 1.48 
g_Dorea 0.14 0.13 0.96 2.16 
g_Lachnobacterium 0.00 0.00 0.00 0.00 
g_Roseburia 0.00 0.00 1.37 2.70 
g_[Ruminococcus] 0.14 0.13 1.65 0.81 
f_Peptostreptococcaceae f_Peptostreptococcaceae_g 10.28 11.70 2.61 9.70 
f_Ruminococcaceae 
f_Ruminococcaceae_Other 0.00 0.00 0.00 0.00 




g_Oscillospira 1.53 2.66 7.69 2.97 




0.00 0.00 0.00 0.00 
f_[Mogibacteriaceae]_g__ 0.14 0.27 0.28 0.14 
f_Erysipelotrichaceae 
f_Erysipelotrichaceae_g__ 0.14 0.00 0.14 0.54 
g_Allobaculum 3.19 6.92 0.69 6.74 
g_Coprobacillus 0.00 0.00 0.00 0.00 
g_p-75-a5 0.00 0.13 0.00 0.00 
g_[Eubacterium] 0.00 0.00 0.00 0.27 




c_Alphaproteobacteria_g_ 0.00 0.00 0.00 0.00 
o_RF32_g__ o_RF32_g__ 0.14 0.00 0.28 0.00 
f_Alcaligenaceae g_Sutterella 0.00 0.00 0.00 0.00 
f_Desulfovibrionaceae 
f_Desulfovibrionaceae_g_ 0.00 0.00 0.14 0.14 
g_Desulfovibrio 0.00 0.13 0.00 0.00 
f_Helicobacteraceae f__Helicobacteraceae_g_ 0.00 0.00 0.00 0.00 
p_Spirochaetes f_Spirochaetaceae g_Treponema 0.00 0.00 0.55 0.40 
p_TM7 f_F16 f_F16_g__ 0.14 0.13 0.00 0.00 
p_Tenericutes o_RF39 o_RF39_g__ 2.22 1.60 0.41 0.00 
 
The Phylogenetic analysis at genus level of faecal 16S rRNA for the four experimental groups (n=6/ 
group). The mean abundance (%) from the bacterial taxonomic profiling is shown. Values <0.01% 
show as 0.00 due to decimal point truncation.  
Key Control= normal diet; STZ-alone= normal diet plus STZ injection; Obese= high fat diet and 






** P<0.01, ***P<0.001 
 







Table S4: Differences of bacterial beta diversity: unweighted (a) and weighted (b) in the 
individual animal samples  
 
a  unweighted   
  
b  weighted 
 NDV1 NDV2 NDV3 NDV4 NDV5 NDV6   NDV1 NDV2 NDV3 NDV4 NDV5 NDV6 
NDV1 0 0.08 0.11 0.11 0.08 0.09  NDV1 0 0.22 0.19 0.08 0.1 0.09 
NDV2 0.08 0 0.08 0.13 0.11 0.12  NDV2 0.22 0 0.05 0.25 0.17 0.27 
NDV3 0.11 0.08 0 0.14 0.13 0.14  NDV3 0.19 0.05 0 0.21 0.15 0.25 
NDV4 0.11 0.13 0.14 0 0.11 0.13  NDV4 0.08 0.25 0.21 0 0.12 0.11 
NDV5 0.08 0.11 0.13 0.11 0 0.07  NDV5 0.1 0.17 0.15 0.12 0 0.14 
NDV6 0.09 0.12 0.14 0.13 0.07 0  NDV6 0.09 0.27 0.25 0.11 0.14 0 
               
 NDS1 NDS2 NDS3 NDS4 NDS5 NDS6   NDS1 NDS2 NDS3 NDS4 NDS5 NDS6 
NDS1 0 0.09 0.08 0.13 0.07 0.09  NDS1 0 0.1 0.1 0.18 0.07 0.09 
NDS2 0.09 0 0.13 0.16 0.12 0.1  NDS2 0.1 0 0.1 0.14 0.08 0.08 
NDS3 0.08 0.13 0 0.11 0.06 0.09  NDS3 0.1 0.1 0 0.21 0.09 0.11 
NDS4 0.13 0.16 0.11 0 0.1 0.12  NDS4 0.18 0.14 0.21 0 0.18 0.14 
NDS5 0.07 0.12 0.06 0.1 0 0.08  NDS5 0.07 0.08 0.09 0.18 0 0.08 
NDS6 0.09 0.1 0.09 0.12 0.08 0.0  NDS6 0.09 0.08 0.11 0.14 008 0.1 
               
 HFV1 HFV2 HFV3 HFV4 HFV5 HFV6   HFV1 HFV2 HFV3 HFV4 HFV5 HFV6 
HFV1 0 0.09 0.07 0.09 0.1 0.1  HFV1 0 0.11 0.03 0.14 0.16 0.08 
HFV2 0.09 0 0.09 0.07 0.11 0.08  HFV2 0.11 0 0.12 0.11 0.09 0.08 
HFV3 0.07 0.09 0 0.07 0.13 0.09  HFV3 0.03 0.12 0 0.15 0.18 0.09 
HFV4 0.09 0.07 0.07 0 0.11 0.07  HFV4 0.14 0.11 0.15 0 0.09 0.1 
HFV5 0.1 0.11 0.13 0.11 0 0.12  HFV5 0.16 0.09 0.18 0.09 0 0.13 
HFV6 0.1 0.08 0.09 0.07 0.12 0  HFV6 0.08 0.08 0.09 0.1 0.13 0 
               
 HFS2 HFS3 HFS4 HFS5 HFS6 HFS1   HFS2 HFS3 HFS4 HFS5 HFS6 HFS1 
HFS2 0.00 0.15 0.15 0.14 0.16 0.17  HFS2 0.00 0.10 0.24 0.17 0.23 0.14 
HFS3 0.15 0.00 0.14 0.17 0.18 0.08  HFS3 0.10 0.00 0.19 0.12 0.16 0.14 
HFS4 0.15 0.14 0.00 0.11 0.12 0.18  HFS4 0.24 0.19 0.00 0.13 0.13 0.18 
HFS5 0.14 0.17 0.11 0.00 0.14 0.21  HFS5 0.17 0.12 0.13 0.00 0.12 0.15 
HFS6 0.16 0.18 0.12 0.14 0.00 0.22  HFS6 0.23 0.16 0.13 0.12 0.00 0.22 
HFS1 0.17 0.08 0.18 0.21 0.22 0.00  HFS1 0.14 0.14 0.18 0.15 0.22 0.00 
Key: NDV = normal diet; NDS = normal diet plus STZ injection; HFV = high fat diet (Obese); HFS = 







Figure S5: Bacterial β-diversity (weighted UniFrac) of the microbial communities 
 





Figure S6: PICRUSt analysis of microbial communities at level 2 (a) and level 3; Hierarchical clustering (b) and heatmap (c) 
Hierarchical clustering and Heat map analysis by R statistic (n=6). The Hierarchical clustering was used to confirm the similarity of bacterial function between the groups. 
Heatmap was use to illustrate the relative abundant of each individual bacterial function among these four groups. Key NDV = normal diet (Control); NDS = normal diet plus 








Figure S7: Correlations between bacteria and metabolic activities  
Linear correlation Pearson coefficients and nonparametric Spearman were used to show the 
relationship of gut bacteria either with SCFAs (butyric acid (a), propionic acid (b) ) and LPS 
biosynthesis (c) and the relative abundance of bacteria that produce butyric acid (d) and propionic acid 
(e).  
 
